Phreesia, Inc. (NYSE: PHR) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $780M. The Maz Rating grades it against the other companies in its sector.
Phreesia, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $12.56, Phreesia, Inc. trades at 72.9x trailing earnings, 1.5x sales and 2.1x book value, with an EV/EBITDA of 13.8. Over the last twelve months it generated about $508M of revenue and $11M of net income. It runs a gross margin of 63.5%, an operating margin of 3.2% and a net margin of 2.1%. It shows return on equity of 3.0%, return on invested capital of 3.2% and a free cash flow yield of 9.9%. On the balance sheet: a debt-to-equity ratio of 0.18 and a current ratio of 1.76. Over the past 52 weeks the share price ranged from $7.77 to $21.24, with a beta of 0.84.
Phreesia, Inc. does not currently pay a dividend.
26 Wall Street analyst ratings cover the stock: 18 Buy, 7 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of July 2026, Phreesia, Inc. (PHR) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 8.92% / 30% · (Cash+Inv) / Mkt Cap (36m) 19.8% / 30% · Interest income / Revenue 0.19% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 8.92% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 10.4% / 33% · Receivables / Mkt Cap (36m) 19.1% / 49% · Interest income / Revenue 0.19% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 8.92% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 10.4% / 33.33% · Receivables / Mkt Cap (24m) 19.1% / 33.33% · Interest income / Revenue 0.19% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 10.6% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 13.7% / 33.33% · Receivables / Avg Assets (4Q) 21.7% / 33.33% · Interest income / Revenue 0.19% / 5% | Pass |
| FTSE | Debt / Total Assets 9.69% / 33.33% · (Cash+ST Inv) / Total Assets 11.3% / 33.33% · (Cash+Recv) / Total Assets 32.0% / 33.33% · Interest income / Revenue 0.19% / 5% | Pass |
Yes. As of July 2026, Phreesia, Inc. (PHR) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Phreesia, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 0.19% of each dividend: Phreesia, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated July 31, 2026 (Q2 2027). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.